IL6 and depressive symptom measurement: Increased concentrations of biomarkers of low-grade inflammation such as C-reactive protein (CRP; >3 mg/L) have been identified,4 together with elevated levels of interleukin (IL)-6 and other inflammatory cytokines in blood and cerebrospinal fluid5–9 of patients with depression.